ANDREA IKEN TENNISON: Open Payments
NPI 1972547800 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,061 in 107 payments from 12 companies in 2025. Trend: 2023 $215 · 2024 $838 · 2025 $2,061
Food & beverage: $1,904Education: $157
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 38 | $515 |
| E.R. Squibb & Sons, L.L.C. | 12 | $317 |
| Alkermes, Inc. | 13 | $275 |
| Janssen Pharmaceuticals, Inc | 8 | $233 |
| Vanda Pharmaceuticals Inc. | 6 | $175 |
| Neurocrine BioSciences, Inc. | 9 | $168 |
| Otsuka America Pharmaceutical, Inc. | 11 | $156 |
| Axsome Therapeutics, Inc. | 4 | $95 |
| Supernus Pharmaceuticals, Inc. | 1 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
Products named: COBENFY, UZEDY, INVEGA SUSTENNA, FANAPT, INGREZZA, VIVITROL, ABILIFY ASIMTUFII, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
